Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
The Latest Google Headlines on:
The Latest Bing News on:
- Dexamethasone May Be Detrimental to Immunotherapy in Glioblastoma Patientson November 25, 2020 at 12:00 pm
Historically, patients with glioblastoma have been empirically treated with dexamethasone, even without symptoms, with many clinicians prescribing steroids for prolonged periods of time, out of a ...
- Allergy Immunotherapy Market Size to record 10.85% CAGR over 2020-2027on November 25, 2020 at 5:26 am
Global Allergy Immunotherapy Market is valued approximately USD 2.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.85% over the forecast period 2020-2027.
- Global Allergy Immunotherapy (AIT) Market to 2024 - Size & Forecast with Impact Analysis of COVID-19 - ResearchAndMarkets.comon November 25, 2020 at 3:35 am
ResearchAndMarkets.com The “Global Allergy Immunotherapy (AIT) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)” report has been added to ResearchAndMarkets.com’s offering.
- Why immunotherapy only works for some with head and neck canceron November 24, 2020 at 6:27 am
University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, while others don't.
- Most Cost-effective to Use Immunotherapy First in Melanomaon November 24, 2020 at 5:08 am
Up-front immunotherapy is the most cost-effective option for treating newly diagnosed unresectable stage III or IV melanoma with unknown BRAF mutation status, concludes a modeling analysis.
- Carbon ions team up with immunotherapy to tackle advanced tumourson November 24, 2020 at 2:34 am
Carbon-ion radiotherapy combined with immune checkpoint inhibitors could offer a promising new approach for treatment of metastatic cancer ...
- Global cancer immunotherapy market size to reach USD 117.82 billion by 2026on November 24, 2020 at 2:00 am
According to industry experts, global cancer immunotherapy market size is projected to reach USD 117.82 billion by the year 2026. Spike in the number of cases of cancer and associated deaths is ...
- New type of immunotherapy may pave the way for better cancer treatmentson November 23, 2020 at 12:02 pm
Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available 10 years ago. However, there are certain types of cancer that do not ...
- Reprogramming T cells into highly active 'super immune cells' can improve immunotherapy benefitson November 23, 2020 at 10:43 am
Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active "super immune cells" with strong antitumor activity, according to ...
- COVID-19 Outbreak- Global Cancer Immunotherapy Market 2020 Key Players, Industry Overview, Supply Chain and Analysis to 2025on November 22, 2020 at 7:57 pm
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed ...
The Latest Google Headlines on:
Artificial intelligence diagnostics
The Latest Bing News on:
Artificial intelligence diagnostics
- Artificial Intelligence in Medical Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025on November 27, 2020 at 6:31 am
The Artificial Intelligence in Medical Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, ...
- Artificial Intelligence in Healthcare Global Market - Forecast to 2027on November 27, 2020 at 5:04 am
Reportlinker.com announces the release of the report "Artificial Intelligence in Healthcare Global Market - Forecast to 2027" - https:/ ...
- Artificial Intelligence in the Telecommunication Market to See Massive Growth by 2025 : Intel, Cisco Systems, Alphabet, IBMon November 26, 2020 at 1:07 pm
A latest survey on Global Artificial Intelligence in the Telecommunication Market is conducted to provide hidden gems performance analysis. The study is a perfect mix of qualitative and quantitative ...
- Optomed launches Aurora IQ, handheld fundus camera with integrated artificial intelligence for faster eye screeningon November 26, 2020 at 4:37 am
Optomed launches its latest camera product, Aurora IQ in a global launch webinar on 26 th of November. The camera has new image quality and usability features and it seamlessly integrates artificial ...
- Artificial intelligence helps check 500,000 CT scans for COVID-19 in Moscowon November 25, 2020 at 8:48 am
The Mayor added that the capital healthcare system actively implements digital technologies that help with diagnostics and perform routine tasks ...
- A new kind of artificial intelligence provides breakthrough in breast cancer diagnosison November 20, 2020 at 6:58 am
State-of-the-art technology which helps doctors more accurately diagnose breast cancer has been hailed as a breakthrough by the US Food & Drugs Administration (FDA) for its exceptional potential ...
- Artificial Intelligence in Diagnostic Market Register Growth 33.2% by 2027on November 19, 2020 at 7:18 am
Precedence Research, Recently Published Report on " Artificial Intelligence in Diagnostics Market (By Component: Hardware, Software and Services; By Diagnosis Type: Radiology, Pathology, Cardiology, ...
- Artificial intelligence for the detection of vertebral fractures on plain spinal radiographyon November 18, 2020 at 11:17 am
Vertebral fractures (VFs) cause serious problems, such as substantial functional loss and a high mortality rate, and a delayed diagnosis may further worsen the prognosis. Plain thoracolumbar ...
- Joint Artificial Intelligence Center Has Substantially Grown To Aid The Warfighteron November 18, 2020 at 5:52 am
It was just two years ago when the Joint Artificial Intelligence Center was created to grab the ... and distribution of safe and effective vaccines, therapeutics, and diagnostics to counter COVID-19 ...
- Dekel Gelbman Joins Day Zero Diagnostics as Senior Vice President of Business Development and Strategyon November 17, 2020 at 5:07 am
Day Zero Diagnostics Inc., an infectious disease diagnostics company utilizing genome sequencing and machine learning to combat the rise of antibiotic-resistant infections, today announced the ...